Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Google Ventures
Biotech
J&J, Google venture arms line up to back EpiBiologics' series B
Protein degradation biotech EpiBiologics brought in $107 million in a series B round headed up by J&J's and Google's respective venture arms.
James Waldron
Jan 8, 2026 9:05am
It's curtain close for Spotlight: Gene editing biotech shutters
Feb 19, 2025 4:28pm
GV, Sanofi drive preclinical British biotech to $100M series B
Apr 28, 2022 2:00am
DNAnexus snags $200M to grow genomic data analytics tech
Mar 8, 2022 1:00pm
Seismic, padded by ex-Pandion C-suite, unveils with $101M
Feb 9, 2022 7:00am
Leyden nabs $140M to stop viruses 'at the gate' with nasal spray
Jan 25, 2022 7:00am
